Abstract
In summary, the discussion by Professors Helmchen and Müller-Oerlinghausen of the morality of clinical trials has emphasized a point that is frequently overlooked. It is an essential to consider those situations in which it might be unethical not to conduct a trial as it is to be concerned about the ways in which trials might restrict the rights of the individuals taking part in them. They and I have dealt mainly with the first of these two issues because it has been relatively neglected. The second is, of course, equally important and has rightly received much attention. Both matters deserve further public discussion.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hirsch S. R., Gaind R., Rohde P. D., Stevens B. C., Wing J. K. Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry. Br Med J. 1973 Mar 17;1(5854):633–637. doi: 10.1136/bmj.1.5854.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leff J. P. Influence of selection of patients on results of clinical trials. Br Med J. 1973 Oct 20;4(5885):156–158. doi: 10.1136/bmj.4.5885.156. [DOI] [PMC free article] [PubMed] [Google Scholar]